Regis Healthcare Limited (ASX: REG) has downgraded its FY2020 guidance due to continued industry pressure on occupancy. Occupancy for FY to date, as at Dec 2019 was 92%. The spot occupancy which was 92.4% as at 30 June 2019 declined to 91.5% as at 17 December 2019.
- The previous guidance for FY20 was normalised EBITDA of circa $105m and normalised NPAT of circa $38 million;
- FY20 guidance is now circa $92 million normalised EBITDA and circa $28 million normalised NPAT.
There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.
Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.
As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.